SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pieris Pharmaceuticals, Inc. - PIRSPRNewsWire • 07/21/20
Pieris Pharmaceuticals' (PIRS) CEO Steve Yoder on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/11/20
Pieris Pharmaceuticals (PIRS) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 05/01/20
Pieris Pharmaceuticals, Inc. (PIRS) CEO Stephen Yoder on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/12/20
Earnings Preview: Pieris Pharmaceuticals (PIRS) Q4 Earnings Expected to DeclineZacks Investment Research • 03/09/20
Pieris Pharmaceuticals, Inc. (PIRS) CEO Stephen Yoder on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/11/19
Pieris Pharmaceuticals' (PIRS) CEO Steve Yoder on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/02/19
Implied Volatility Surging for Pieris Pharmaceuticals (PIRS) Stock OptionsZacks Investment Research • 05/31/19
Pieris Pharmaceuticals, Inc. (PIRS) CEO Stephen Yoder on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/10/19